Allegro Diagnostics Obtains $5,400,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c49664e6-2ddf-4d6b-9c65-16defd23203c&Preview=1 -
Date
7/7/2011 -
Company Name
Allegro Diagnostics -
Mailing Address
6 Clock Tower Place Maynard, MA 01754 -
Company Description
Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases. -
Website
http://www.allegrodx.com -
Transaction Type
Venture Equity -
Transaction Amount
$5,400,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds from the financing will support the commercialization of Allegro’s lead genomic test, BronchoGen, in 2012. -
M&A Terms
-
Venture Investor
Kodiak Venture Partners -
Venture Investor
Catalyst Health Ventures
